CLCA4 | Chloride channel accessory 4 | Predicted membrane proteins
| | | | | Group enriched |
CTSV | Cathepsin V | Enzymes Predicted secreted proteins
| | | | | Group enriched |
DSG3 | Desmoglein 3 | Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
DSP | Desmoplakin | Cytoskeleton related proteins Disease related genes Plasma proteins
| | | | | Group enriched |
ECM1 | Extracellular matrix protein 1 | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
FAT2 | FAT atypical cadherin 2 | Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
FGFBP1 | Fibroblast growth factor binding protein 1 | Cancer-related genes Predicted secreted proteins
| | | | | Tissue enriched |
GBP6 | Guanylate binding protein family, member 6 | | | | | | Tissue enriched |
GJB2 | Gap junction protein, beta 2, 26kDa | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
GJB5 | Gap junction protein, beta 5, 31.1kDa | Cancer-related genes Predicted membrane proteins
| | | | | Group enriched |
HMGN4 | High mobility group nucleosomal binding domain 4 | | | | | | Tissue enriched |
IL36RN | Interleukin 36 receptor antagonist | Disease related genes
| | | | | Group enriched |
KCNA5 | Potassium voltage-gated channel, shaker-related subfamily, member 5 | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Group enriched |
KLK13 | Kallikrein-related peptidase 13 | Cancer-related genes Enzymes Predicted secreted proteins
| | | | | Tissue enriched |
KLK6 | Kallikrein-related peptidase 6 | Cancer-related genes Enzymes Mitochondrial proteins Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
KRT31 | Keratin 31 | Plasma proteins
| | | | | Group enriched |
KRT5 | Keratin 5 | Disease related genes Plasma proteins
| | | | | Group enriched |
LY6D | Lymphocyte antigen 6 complex, locus D | Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
MAL | Mal, T-cell differentiation protein | Predicted membrane proteins
| | | | | Tissue enriched |
PADI1 | Peptidyl arginine deiminase, type I | Enzymes
| | | | | Tissue enriched |
PAX9 | Paired box 9 | Disease related genes Transcription factors
| | | | | Group enriched |
PITX1 | Paired-like homeodomain 1 | Disease related genes Transcription factors
| | | | | Group enriched |
RBFOX3 | RNA binding protein, fox-1 homolog (C. elegans) 3 | | | | | | Group enriched |
RHBG | Rh family, B glycoprotein (gene/pseudogene) | Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Group enriched |
RP11-167N24.6 | Uncharacterized protein | | | | | | Group enriched |
SDR16C5 | Short chain dehydrogenase/reductase family 16C, member 5 | Enzymes Predicted membrane proteins
| | | | | Group enriched |
SERPINB2 | Serpin peptidase inhibitor, clade B (ovalbumin), member 2 | Cancer-related genes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
SFN | Stratifin | Cancer-related genes Plasma proteins
| | | | | Group enriched |
SLC10A6 | Solute carrier family 10 (sodium/bile acid cotransporter), member 6 | Predicted membrane proteins
| | | | | Group enriched |
SLC39A2 | Solute carrier family 39 (zinc transporter), member 2 | Predicted membrane proteins
| | | | | Group enriched |
SPRR1B | Small proline-rich protein 1B | Cancer-related genes
| | | | | Group enriched |
TGM1 | Transglutaminase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enriched |
TMPRSS11B | Transmembrane protease, serine 11B | Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
UPK1A | Uroplakin 1A | Predicted membrane proteins
| | | | | Group enriched |
VSIG10L | V-set and immunoglobulin domain containing 10 like | Predicted membrane proteins
| | | | | Group enriched |
BTBD11 | BTB (POZ) domain containing 11 | | | | | | Group enriched |
CEACAM6 | Carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen) | Cancer-related genes CD markers Predicted membrane proteins
| | | | | Group enriched |
CLIC3 | Chloride intracellular channel 3 | Plasma proteins Transporters
| | | | | Group enriched |
CRABP2 | Cellular retinoic acid binding protein 2 | | | | | | Tissue enriched |
DENND2C | DENN/MADD domain containing 2C | | | | | | Group enriched |
EFNA3 | Ephrin-A3 | Predicted membrane proteins RAS pathway related proteins
| | | | | Group enriched |
ERO1L | ERO1-like (S. cerevisiae) | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
FBXL16 | F-box and leucine-rich repeat protein 16 | | | | | | Group enriched |
KLC3 | Kinesin light chain 3 | | | | | | Group enriched |
KLK8 | Kallikrein-related peptidase 8 | Cancer-related genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
KRT6A | Keratin 6A | Disease related genes Plasma proteins
| | | | | Tissue enriched |
KRT78 | Keratin 78 | Plasma proteins
| | | | | Tissue enriched |
PGLYRP3 | Peptidoglycan recognition protein 3 | Predicted secreted proteins
| | | | | Group enriched |
PLA2G3 | Phospholipase A2, group III | Enzymes Predicted secreted proteins RAS pathway related proteins
| | | | | Group enriched |
RP11-817J15.3 | Uncharacterized protein | | | | | | Group enriched |